• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10617
Device Problems Difficult or Delayed Positioning (1157); Migration (4003)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/09/2021
Event Type  Injury  
Event Description
It was reported that stent partial deployment occurred.Vascular access was obtained via right femoral artery.The 95% stenosed, 4.5mm x 10mm, de novo target lesion was located in the mildly tortuous and mildly calcified right coronary artery.Following pre-dilation with 3.50x15 and 3.50x13 non-boston scientific balloons, a 4.00 x 12 mm synergy drug-eluting stent (des) was advanced for treatment.Two to three attempts were made to position the stent at the lesion site.When the stent was in position, the balloon was inflated to six atmospheres but the stent only expanded in the proximal and distal end; the middle did not expand.The stent slipped out of the aorta and dislodged to the axillary and an attempt was made to reposition.The procedure was completed with a 4.00 x 16mm synergy des.No patient complications were reported and the patient was stable.The patient will return for an x-ray after three months to see if the 4.00 x 12 mm stent remained stable or if it had migrated.
 
Manufacturer Narrative
The synergy ous mr 4.00 x 12 stent delivery system was returned for analysis.The stent was not returned with the delivery device.As a result, it was not possible to measure the outer diameter (od) of the crimped in accordance with device specification.A review was performed into the manufacturing stent crimp data for this batch.The crimped stent od was measured at the time of manufacture within maximum stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.Evidence of the stent crimp was visible on the balloon.A visual and microscopic examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found no kink or damages.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.The device was soaked overnight in a water bath in order to facilitate inflation.A 0.014 test guidewire was inserted through the wire lumen with no resistance noted.An encore inflation unit was used to inflate the device to its rated burst pressure with no issues noted.A vacuum was pulled and the balloon deflated fully in approximately 6 seconds.
 
Event Description
It was reported that stent partial deployment occurred.Vascular access was obtained via right femoral artery.The 95% stenosed, 4.5mm x 10mm, de novo target lesion was located in the mildly tortuous and mildly calcified right coronary artery.Following pre-dilation with 3.50x15 and 3.50x13 non-boston scientific balloons, a 4.00 x 12 mm synergy drug-eluting stent (des) was advanced for treatment.Two to three attempts were made to position the stent at the lesion site.When the stent was in position, the balloon was inflated to six atmospheres but the stent only expanded in the proximal and distal end; the middle did not expand.The stent slipped out of the aorta and dislodged to the axillary and an attempt was made to reposition.The procedure was completed with a 4.00 x 16mm synergy des.No patient complications were reported and the patient was stable.The patient will return for an x-ray after three months to see if the 4.00 x 12 mm stent remained stable or if it had migrated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12858044
MDR Text Key281203153
Report Number2134265-2021-14712
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeTH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/22/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/19/2023
Device Model Number10617
Device Catalogue Number10617
Device Lot Number0027217278
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2021
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/19/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE CATHETER: LAUNCHER JR 3.5/6FR; GUIDE CATHETER: LAUNCHER JR 3.5/6FR; GUIDEWIRE: RUNTHROUGH NS EXTRA FLOPPY 0.014; GUIDEWIRE: RUNTHROUGH NS EXTRA FLOPPY 0.014
Patient Outcome(s) Required Intervention;
Patient Age55 YR
Patient SexMale
Patient Weight83 KG
-
-